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Respiratory syncytial virus (RSV) is the major cause of lower respiratory tract infections in children worldwide. Early detection
of RSV is critical to initiate proper care. Two methods, the direct ﬂuorescence assay (DFA) and the real-time reverse-transcription
polymerase chain reaction (rt-RT-PCR), that are used for RSV detection were compared. A total of 451 nasopharyngeal aspirates
from children 5 years of age or less were tested for RSV using both methods. The overall prevalence rate of the RSV among the
children was 23.7% with a signiﬁcantly higher prevalence among children under the age of 6 months of age when compared to
other age groups. The sensitivity of DFA in comparison to rt-RT-PCR was highest (86%) during the ﬁrst 3 days of symptoms
onset and decreased gradually till it reached 65% after the ﬁrst week. The speciﬁcity of DFA in comparison to rt-RT-PCR ranged
between 99 and 100% irrespective of the date of collection. We concluded that, although the rt-RT-PCR is more sensitive for RSV
detection, the DFA oﬀers a reliable point-of-care alternative detection method especially during the ﬁrst few days of illness.
1.Introduction
Respiratory syncytial virus (RSV) is a negative sense single-
stranded RNA virus belonging to Pneumovirus genus, sub-
family Pneumovirinae. RSV is considered a major cause of
severe lower respiratory tract infections in children less than
two years of age worldwide [1]. Morbidity and mortality are
greatly increased in children with bacterial coinfections or
superinfections [2]. Therefore, early detection of the virus
is a critical step in the initiation of proper care, and the
preventionoffurtherspreadofthevirusinpublicplacessuch
asschoolsandhealthcarefacilities.DirectFluorescenceassay
(DFA) is a conventional method that is frequently used in
the clinical setting for the detection of respiratory viruses
including RSV. However, nucleic acid detection methods
have proven to be more sensitive for RSV detection [3].
Some countries, particularly developing countries, cannot
aﬀord to use nucleic acid detection methods within hospital
laboratories due to high cost and lack of technical expertise.
In this study, we compared the sensitivity and speciﬁcity of
the DFA against real-time reverse transcriptase polymerase
chain reaction (rt-RT-PCR) as a point-of-care method for
RSV detection. Comparison was also made between both
assays in relation to the days after onset of symptoms.
2.MaterialsandMethods
Four hundred and ﬁfty one specimens were collected be-
tween December, 2006 and November, 2007 from patients
presenting to Abou El Rish Pediatric Hospital, Cairo, Egypt,
with acute lower respiratory tract infection (ALRTI) as per
the WHO case deﬁnition (WHO/CDS/2004.25). For each
patient that met the criteria, a nasopharyngeal aspirate
(NPA) was collected using the infant mucous extractor
(ARGYLE DeLee, Kendall, USA). Clinical history including
the date of onset of symptoms was recorded. Virus transport
mediawasaddedtoeachNPAandwassplitintotwoaliquots,
one for direct ﬂuorescent assay (DFA) and the second for
nucleicacidextraction.ForDFA,anepithelialcellsuspension
in phosphate buﬀered saline was prepared for each sample
and air-dried on multiwell Teﬂon slides. The Respiratory
Panel 1 DFA kit (LIGHT DIAGNOSTICS Millipore, Calif,
USA) was used for DFA. Total nucleic extraction was2 Journal of Tropical Medicine
performed using MagMax Express96 (Applied Biosystems)
and the Total Nucleic Acid Isolation Kit (Ambion) per man-
ufacturer’s instructions. rt-RT-PCR was performed as per
Centers for Disease Control and Prevention (CDC), Atlanta,
Ga, USA using CDC’s primers. A sample was considered
positive for RSV if its cycle threshold (Ct) was ≤38.
StatisticalsigniﬁcancewasdeterminedbyChi-squareand
Fisher’s exact t-test using EpiInfo software, version 6.04
In this study, rt-RT-PCR served as the standard test, and
sensitivity and speciﬁcity of DFA were calculated on the basis
thePCRresults.SensitivityofDFAwascalculatedbydividing
the number of samples positive for RSV by both DFA and
rt-RT-PCR by the total number of samples positive by rt-
RT-PCR. Speciﬁcity of DFA was calculated by dividing the
number of samples negative by both DFA and rt-RT-PCR by
the total number of samples negative by rt-RT-PCR.
Positive Predictive Value (PPV) of DFA was calculated by
dividing the number of samples positive by both DFA and
rt-RT-PCR by the total number of DFA positive samples.
negative predictive value (NPV) was calculated by dividing
thenumberofsamplesnegativebybothDFAandrt-RT-PCR
by the total number of DFA negative samples.
3. Results
A total of 451 patients were enrolled in this study. The age
range of patients was 0–60 months, 41.5% were between 0
and 6 months of age. The prevalence rate of RSV in this
study population by the two assays was 23.7% (107/451).
Patientsaged0–6monthshadastatisticallysigniﬁcanthigher
rate of RSV infection compared to in the other age groups
(Figure 1).
The overall sensitivity of DFA for RSV detection was
77.8% and speciﬁcity 99.6%. The PPV for DFA was 98.6%,
and the NPV was 94%.
We examined the eﬀect of sample collection date in
relation to date of onset of symptoms on the DFA sensitivity
for detection of RSV. The DFA was 86% sensitive and 99%
speciﬁc between 0 and 3 days after onset of symptoms. The
sensitivity of DFA dropped to 75.8% when samples were
collected 4–7 days after onset of symptoms and was 100%
speciﬁc. DFA was only 65% sensitive when samples were
collected 8 days and more after symptom onset, and the
speciﬁcity remained at 100%, indicating that the assay is still
reliable (Figure 2).
4. Conclusion
The rate of RSV prevalence was successfully monitored using
two clinical diagnostic assays. The rate of RSV infection
was signiﬁcantly higher among children aged 0–6 months
old, which is in accordance with other studies [4]. Both
assays are very speciﬁc and have good predictive value for
diagnosis. In general, rt-RT-PCR is more sensitive than
DFA for detection of RSV. The downfall of this technique
is the expense and that it is not currently available in
many clinical settings, especially in developing countries.
Therefore, we also examined the commonly used DFA assay
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Figure 1: Age distribution of the RSV-positive patients.
∗Statistically signiﬁcant diﬀerence (P<0.05).
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Figure 2: RSV-positive samples detected by each method at
diﬀerent times after onset of symptoms. SEN: sensitivity of DFA,
SPEC: speciﬁcity of DFA, PPV: positive predictive value, and NPV:
negative predictive value.
for the detection of RSV in a clinical setting. DFA still oﬀers
a reliable option for the detection of RSV especially for
patients tested with the ﬁrst 3 days after onset of symptoms.
Successful RSV testing during the ﬁrst days of illness enables
the physician to make the best decision regarding treatment
for the child and prevent the spread of infection especially
within health care facilities.
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